Used in the synthesis of complex peptide-based pharmaceuticals, particularly in the development of protease inhibitors. Its structure supports selective binding and enhanced stability in biological environments, making it valuable in drug design for diseases involving protein misfolding or enzymatic overactivity. Commonly employed as an intermediate in creating targeted therapies, including antiviral and anticancer agents. The protecting groups allow for stepwise, controlled peptide coupling in solid-phase and solution-phase synthesis.